Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06912724 · ClinicalTrials.gov registry record

Pediatric Neuroimaging

A clinical trial of Neurogimaging, sponsored by National Institute on Aging (NIA).

Recruiting
Registry status
80
Enrollment target
1
Study location

NCT06912724: Recruiting study of Neurogimaging, sponsored by National Institute on Aging (NIA).

NCT06912724 is a study of Neurogimaging that is actively recruiting participants, run by National Institute on Aging (NIA). The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06912724, a study of Neurogimaging, is actively recruiting participants, sponsored by National Institute on Aging (NIA).

RECRUITING
Registry status
80 participants
Enrollment target
1
Study location

Study Summary

Background: Puberty is a normal part of life. Many big changes occur in all parts of the body as a child matures into an adult. Researchers in this study want to find out more about how the brain changes during puberty. Objective: To study changes that occur in the brain before, during, and after puberty. Eligibility: Healthy children aged 9 to 14 years. Design: Participants will have 2 clinic visits. Each visit will last up to 4 hours. In the first visit, participants will be screened: They will have a physical exam with blood tests. They will complete a mental health questionnaire on a computer. They will undergo a mock magnetic resonance imaging (MRI) scan. Participants will be made comfortable as they lie on the table and slide into the big tube. They will learn what it feels and sounds like to lie still inside a real MRI. At the second visit, participants will have more tests: They will have a physical exam with blood tests. This time the doctor will check for their stage of puberty. The doctor will look at and touch their genitals and breasts. They will have a real MRI exam. An x-ray will be taken of their hand and wrist. This will show how their bones are maturing. They will have a DEXA scan. They will lie on a table while a machine uses x-rays to measure the makeup of their bodies, including bone, muscle, and fat. They will have a 3D body scan. They will wear tight clothes and a shower cap. They will stand on a platform while sensors take pictures of their body.

Primary Outcome

Number of participants with high-quality BMC-mcDESPOT and C-NODDI MRI data

Conditions Studied

Study Locations (1)

Maryland

  • National Institute of Aging, Clinical Research Unit - Baltimore

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-04-21
Est. Completion 2026-06-01
National Institute on Aging (NIA)

131 total trials

What NCT06912724 shows while recruiting

NCT06912724 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.

The record links to 1 condition, with Neurogimaging appearing as the primary indexed condition, and to 0 interventions.

NCT06912724 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06912724 about?

NCT06912724 is a clinical study titled "Pediatric Neuroimaging". Background: Puberty is a normal part of life. Many big changes occur in all parts of the body as a child matures into an adult. Researchers in this study want to find out more about how the brain changes during puberty. Objective: To study changes that occur in the brain before, during, and after...

What is the current status of trial NCT06912724?

This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2025-04-21. Estimated completion is 2026-06-01.

What conditions does trial NCT06912724 study?

This clinical trial studies the following conditions: Neurogimaging.

Who is sponsoring clinical trial NCT06912724?

This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06912724 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06912724, the US trial registry maintained by the National Library of Medicine. NCT06912724 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.